Capstone Investment Advisors
DAWN

Capstone Investment Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Capstone Investment Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-236,000
Closed -$5.06M – 1712
2026
Q1 		$5.06M Buy
+236,000
New +$3.33M 0.01% 415
2025
Q4 		– Sell
-22,642
Closed -$160K – 1702
2025
Q3 		$160K Buy
+22,642
New +$156K ﹤0.01% 1854
2023
Q4 		– Sell
-11,088
Closed -$136K – 2157
2023
Q3 		$136K Buy
+11,088
New +$145K ﹤0.01% 1903

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capstone Investment Advisors's DAWN Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 236,000 shares — an estimated $5.06M sold.

Capstone Investment Advisors first reported a position in DAWN in Q3 2023 and held it in 3 quarters. The position peaked at $5.06M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 236,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $5.06M.
  • Capstone Investment Advisors first reported a position in Day One Biopharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Capstone Investment Advisors's Day One Biopharmaceuticals position peaked at $5.06M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.